Iminodibenzyl | CAS:494-19-9

We serve Iminodibenzyl CAS:494-19-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Iminodibenzyl

Chemical Name:Iminodibenzyl
CAS.NO:494-19-9
Synonyms:Iminodibenzyl
10,11-Dihydro-5H-dibenzo[b,f]azepine
10,11-Dihydro-5H-dibenz[b,f]azepine
 
Physical and Chemical Properties:
Density 1.1±0.1 g/cm3
Boiling Point 327.7±32.0 °C at 760 mmHg
Melting Point 105-108 °C(lit.)
Molecular Formula C14H13N
Molecular Weight 195.260
Flash Point 161.3±20.6 °C
Vapour Pressure 0.0±0.7 mmHg at 25°C
Index of Refraction 1.603
 
Specification:
Appearance:White to light yellow crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Carbamazepine(CAS:298-46-4).



Contact us for information like Iminodibenzyl chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,10,11-Dihydro-5H-dibenz[b,f]azepine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Iminodibenzyl Use and application,10,11-Dihydro-5H-dibenzo[b,f]azepine technical grade,usp/ep/jp grade.


Related News: “And also to make sure that your meat is cooked thoroughly before consuming.”4-[6-amino-2-(4-cyanoanilino)pyrimidin-4-yl]oxy-3,5-dimethylbenzonitrile manufacturer Their pharmacological activity plays a direct role in the diagnosis, cure, mitigation, treatment, or prevention of disease.tert-Butyl isothiocyanate supplier Indonesia is suspending its visa-free travel for Chinese citizens and barring passengers who have visited mainland China in the past 14 days.(R)-3-(4-Bromo-3-fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one vendor A key publication in a preclinical model demonstrated rigosertib’s ability to block cellular signaling by targeting RAS effector pathways (Divakar, S.K., et al., 2016: “A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.” Cell 165, 643).A key publication in a preclinical model demonstrated rigosertib’s ability to block cellular signaling by targeting RAS effector pathways (Divakar, S.K., et al., 2016: “A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.” Cell 165, 643).